Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study

Al balawi et al., Bioresources and Bioprocessing, doi:10.1186/s40643-024-00822-z
Nov 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.002 from 12 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
In Vitro and In Silico study showing that propolis, curcumin, quercetin, and ginseng compounds inhibit SARS-CoV-2 infection and bind to key viral proteins. In Vero CCL-81 cells, propolis and curcumin significantly reduced SARS-CoV-2 viral titer, while quercetin and ginseng required higher concentrations for antiviral effects. Molecular docking predicted that the compounds bind to the SARS-CoV-2 main protease, spike protein, and RNA-directed RNA polymerase. Propolis also reduced inflammatory cytokines TNF-α, IL-1β, and IL-10 in infected cells. The compounds demonstrated strong antioxidant activity, with propolis showing the highest potency.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
73 preclinical studies support the efficacy of quercetin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,3,9,10,22,24,25,30,38,39,41,42,62-64, MproB,3,7,9,11,13,15,17,18,20,23,24,30,34,36-38,42,43,45,63-65, RNA-dependent RNA polymeraseC,1,3,9,32,64, PLproD,3,37,45, ACE2E,22,23,28,37,41,63, TMPRSS2F,22, nucleocapsidG,3, helicaseH,3,29,34, endoribonucleaseI,39, NSP16/10J,6, cathepsin LK,26, Wnt-3L,22, FZDM,22, LRP6N,22, ezrinO,40, ADRPP,38, NRP1Q,41, EP300R,16, PTGS2S,23, HSP90AA1T,16,23, matrix metalloproteinase 9U,31, IL-6V,21,35, IL-10W,21, VEGFAX,35, and RELAY,35 proteins. In Vitro studies demonstrate inhibition of the MproB,15,46,51,59 protein, and inhibition of spike-ACE2 interactionZ,47. In Vitro studies demonstrate efficacy in Calu-3AA,50, A549AB,21, HEK293-ACE2+AC,58, Huh-7AD,25, Caco-2AE,49, Vero E6AF,19,42,49, mTECAG,52, and RAW264.7AH,52 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAI,55, db/db miceAJ,52,61, BALB/c miceAK,60, and rats66. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice60, inhibits LPS-induced cytokine storm by modulating key inflammatory and antioxidant pathways in macrophages5, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity54.
Study covers propolis, quercetin, and curcumin.
a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.
b. The main protease or Mpro, also known as 3CLpro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting Mpro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.
c. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.
d. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.
e. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.
f. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.
g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.
h. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.
i. The endoribonuclease, also known as NendoU or nsp15, cleaves specific sequences in viral RNA which may help the virus evade detection by the host immune system. Inhibition may hinder the virus's ability to mask itself from the immune system, facilitating a stronger immune response.
j. The NSP16/10 complex consists of non-structural proteins 16 and 10, forming a 2'-O-methyltransferase that modifies the viral RNA cap structure. This modification helps the virus evade host immune detection by mimicking host mRNA, making NSP16/10 a promising antiviral target.
k. Cathepsin L is a host lysosomal cysteine protease that can prime the spike protein through an alternative pathway when TMPRSS2 is unavailable. Dual targeting of cathepsin L and TMPRSS2 may maximize disruption of alternative pathways for virus entry.
l. Wingless-related integration site (Wnt) ligand 3 is a host signaling molecule that activates the Wnt signaling pathway, which is important in development, cell growth, and tissue repair. Some studies suggest that SARS-CoV-2 infection may interfere with the Wnt signaling pathway, and that Wnt3a is involved in SARS-CoV-2 entry.
m. The frizzled (FZD) receptor is a host transmembrane receptor that binds Wnt ligands, initiating the Wnt signaling cascade. FZD serves as a co-receptor, along with ACE2, in some proposed mechanisms of SARS-CoV-2 infection. The virus may take advantage of this pathway as an alternative entry route.
n. Low-density lipoprotein receptor-related protein 6 is a cell surface co-receptor essential for Wnt signaling. LRP6 acts in tandem with FZD for signal transduction and has been discussed as a potential co-receptor for SARS-CoV-2 entry.
o. The ezrin protein links the cell membrane to the cytoskeleton (the cell's internal support structure) and plays a role in cell shape, movement, adhesion, and signaling. Drugs that occupy the same spot on ezrin where the viral spike protein would bind may hindering viral attachment, and drug binding could further stabilize ezrin, strengthening its potential natural capacity to impede viral fusion and entry.
p. The Adipocyte Differentiation-Related Protein (ADRP, also known as Perilipin 2 or PLIN2) is a lipid droplet protein regulating the storage and breakdown of fats in cells. SARS-CoV-2 may hijack the lipid handling machinery of host cells and ADRP may play a role in this process. Disrupting ADRP's interaction with the virus may hinder the virus's ability to use lipids for replication and assembly.
q. Neuropilin-1 (NRP1) is a cell surface receptor with roles in blood vessel development, nerve cell guidance, and immune responses. NRP1 may function as a co-receptor for SARS-CoV-2, facilitating viral entry into cells. Blocking NRP1 may disrupt an alternative route of viral entry.
r. EP300 (E1A Binding Protein P300) is a transcriptional coactivator involved in several cellular processes, including growth, differentiation, and apoptosis, through its acetyltransferase activity that modifies histones and non-histone proteins. EP300 facilitates viral entry into cells and upregulates inflammatory cytokine production.
s. Prostaglandin G/H synthase 2 (PTGS2, also known as COX-2) is an enzyme crucial for the production of inflammatory molecules called prostaglandins. PTGS2 plays a role in the inflammatory response that can become severe in COVID-19 and inhibitors (like some NSAIDs) may have benefits in dampening harmful inflammation, but note that prostaglandins have diverse physiological functions.
t. Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1) is a chaperone protein that helps other proteins fold correctly and maintains their stability. HSP90AA1 plays roles in cell signaling, survival, and immune responses. HSP90AA1 may interact with numerous viral proteins, but note that it has diverse physiological functions.
u. Matrix metalloproteinase 9 (MMP9), also called gelatinase B, is a zinc-dependent enzyme that breaks down collagen and other components of the extracellular matrix. MMP9 levels increase in severe COVID-19. Overactive MMP9 can damage lung tissue and worsen inflammation. Inhibition of MMP9 may prevent excessive tissue damage and help regulate the inflammatory response.
v. The interleukin-6 (IL-6) pro-inflammatory cytokine (signaling molecule) has a complex role in the immune response and may trigger and perpetuate inflammation. Elevated IL-6 levels are associated with severe COVID-19 cases and cytokine storm. Anti-IL-6 therapies may be beneficial in reducing excessive inflammation in severe COVID-19 cases.
w. The interleukin-10 (IL-10) anti-inflammatory cytokine helps regulate and dampen immune responses, preventing excessive inflammation. IL-10 levels can also be elevated in severe COVID-19. IL-10 could either help control harmful inflammation or potentially contribute to immune suppression.
x. Vascular Endothelial Growth Factor A (VEGFA) promotes the growth of new blood vessels (angiogenesis) and has roles in inflammation and immune responses. VEGFA may contribute to blood vessel leakiness and excessive inflammation associated with severe COVID-19.
y. RELA is a transcription factor subunit of NF-kB and is a key regulator of inflammation, driving pro-inflammatory gene expression. SARS-CoV-2 may hijack and modulate NF-kB pathways.
z. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.
aa. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.
ab. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.
ac. HEK293-ACE2+ is a human embryonic kidney cell line engineered for high ACE2 expression and SARS-CoV-2 susceptibility.
ad. Huh-7 cells were derived from a liver tumor (hepatoma).
ae. Caco-2 cells come from a colorectal adenocarcinoma (cancer). They are valued for their ability to form a polarized cell layer with properties similar to the intestinal lining.
af. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.
ag. mTEC is a mouse tubular epithelial cell line.
ah. RAW264.7 is a mouse macrophage cell line.
ai. A mouse model expressing the human ACE2 receptor under the control of the K18 promoter.
aj. A mouse model of obesity and severe insulin resistance leading to type 2 diabetes due to a mutation in the leptin receptor gene that impairs satiety signaling.
ak. A mouse model commonly used in infectious disease and cancer research due to higher immune response and susceptibility to infection.
Al balawi et al., 27 Nov 2024, peer-reviewed, 5 authors. Contact: an.albalawi@ut.edu.sa, dr.prof2011@gmail.com.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study
Aisha Nawaf Al Balawi, Jayda G Eldiasty, Sahar Abd-El Razik Mosallam, Alaa R El-Alosey, Alaa Elmetwalli
Bioresources and Bioprocessing, doi:10.1186/s40643-024-00822-z
There is an urgent need for preventive and therapeutic drugs to effectively treat and prevent viral diseases from resurfacing as they emerge during the COVID-19 pandemic. This study aims to assess the antiviral effects of four natural compounds commonly used in traditional medicine to treat SARS-CoV-2 infection. A cytotoxicity, dose-dependent, and plaque reduction assay was performed on Vero CCL-81 cells to figure out their effects on the cells. Quantification of cytokines was assessed. In silico analysis for the selected compound was also evaluated. Results revealed that the compounds could disrupt the viral replication cycle through direct inhibition of the virus or immune system stimulation. The cytotoxicity assay results revealed that the compounds were well tolerated by the cells, indicating that the compounds were not toxic to the cells. This study evaluated the antioxidant capacities of propolis, curcumin, quercetin, and ginseng using ABTS, FRAP, and CUPRAC assays, revealing that propolis exhibited the highest antioxidant activity of ABTS with 1250.40 ± 17.10 μmol Trolox eq/g, with FRAP values reaching 1200.55 ± 15.90 μmol Fe 2 ⁺ eq/g and CUPRAC values of 1150.80 ± 14.20 μmol Trolox eq/g at 1000 µg/mL, highlighting its potential as a potent natural antioxidant. The results of the plaque reduction assay revealed that the compounds could reduce the size and number of plaques, indicating that the compounds could inhibit the virus replication cycle. Subsequently, using molecular docking to analyze the effect of propolis, curcumin, quercetin, and ginseng as inhibitors, it was unveiled that the four compounds are likely to have the potential to inhibit the protease activity, spike protein S1, and RNA polymerase of SARS-CoV-2 and the virus titer was reduced by 100% after post-infection using propolis as an inhibitor control.
Author contributions Conceptualization, Aisha Nawaf Al balawi, Alaa Elmetwalli, Jayda G. Eldiasty; formal analysis, Alaa Elmetwalli, Sahar Abd-El Razik Mosallam, Alaa R. El-Alosey; investigation, Alaa Elmetwalli, Aisha Nawaf Al balawi, Jayda G. Eldiasty, Sahar Abd-El Razik Mosallam; project administration, Alaa Elmetwalli, Aisha Nawaf Al balawi, Jayda G. Eldiasty, Sahar Abd-El Razik Mosallam, Alaa R. El-Alosey; Software, Alaa Elmetwalli, Jayda G. Eldiasty; validation Alaa Elmetwalli, Aisha Nawaf Al balawi; Visualization, Alaa Elmetwalli; writing-original draft, Alaa Elmetwalli; writing-review, editing, and provided critical feedback to help shape the research, analysis, and manuscript, Alaa Elmetwalli; All authors have read and agreed to the published version of the manuscript. Declarations Ethics approval consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Abbas, Abd-Elhakeem, Galil, Natural immunomodulators treat the cytokine storm in SARS-CoV-2, Adv Pharm Bull
Ahmad, Chemical constituents, antioxidant potential, and antimicrobial efficacy of Pimpinella anisum extracts against multidrug-resistant bacteria, Microorganisms
Allam, Jones, On the coronavirus (COVID-19) outbreak and the smart city network: universal data sharing standards coupled with artificial intelligence (AI) to benefit urban health monitoring and management
Alsayari, Bin, Almaghaslah, Pharmacological efficacy of ginseng against respiratory tract infections, Molecules
Araf, Akter, Tang, Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines, J Med Virol
Araujo, Machado, Amgarten, SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network, Mem Inst Oswaldo Cruz
Asif, Pasha, Shafiq, Craine, Economic impacts of post COVID-19, Inverge J Soc Sci
Asma, Bobiş, Bonta, General nutritional profile of bee products and their potential antiviral properties against mammalian viruses, Nutrients
Badraoui, Alrashedi, El-May, Bardakci, Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19, J Biomol Struct Dyn
Badraoui, Saoudi, Hamadou, Antiviral effects of artemisinin and its derivatives against SARS-CoV-2 main protease: computational evidences and interactions with ACE2 allelic variants, Pharmaceuticals
Bafna, White, Harish, Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture, Cell Rep
Bakacs, Sandig, Kovesdi, An orally administered nonpathogenic attenuated vaccine virus can be used to control SARS-CoV-2 infection: a complementary plan B to COVID-19 vaccination, Cureus, doi:10.7759/cureus.28467
Baker, Can natural products modulate cytokine storm in SARS-CoV2 patients?, Biotechnol Reports
Bardhan, Ray, Roy, Emerging zoonotic diseases and COVID-19 pandemic: global perspective and Indian scenario, Ann Med Surg
Ben-Nasr, Badraoui, Approach of utilizing Artemisia herbs to treat covid-19, Brazilian J Pharm Sci
Berretta, Silveira, Capcha, Jong, Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: running title: propolis against SARS-CoV-2 infection and COVID-19, Biomed Pharmacother
Bhargava, Mahanta, Kaul, Experimental evidence for therapeutic potentials of propolis, Nutrients
Bhatti, Bhatti, Khullar, Therapeutic strategies in the development of antiviral drugs and vaccines against SARS-CoV-2 infection, Mol Neurobiol
Braakhuis, Evidence on the health benefits of supplemental propolis, Nutrients
Costanzo, Giglio, Roviello, Anti-coronavirus vaccines: past investigations on SARS-CoV-1 and MERS-CoV, the approved vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under development against SARSCoV-2 infection, Curr Med Chem
Da Cunha, Tizziani, Souza, Natural products with tandem anti-inflammatory, immunomodulatory and anti-SARS-CoV/2 effects: a drug discovery perspective against SARS-CoV-2, Curr Med Chem
De Sales-Peres, De Azevedo-Silva, Castilho, Propolis effects in periodontal disease seem to affect coronavirus disease: a metaanalysis, Braz Oral Res
Deepika, Health benefits of quercetin in age-related diseases, Molecules
Delgado-Roche, Mesta, Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection, Arch Med Res
Desai, Mahitha, Ayurnano: a solution towards herbal therapeutics using artificial intelligence approach
Dias, Soares, Ferreira, Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators, PLoS Pathog
Eberle, Olivier, Amaral, The repurposed drugs suramin and quinacrine cooperatively inhibit SARS-CoV-2 3CLpro in vitro, Viruses
El-Alosey, Eldiasty, Abushalfeh, Perceptions of medicinal herbal products during the COVID-19 pandemic period among Saudi patients: a cross-sectional study, Naunyn Schmiedebergs Arch Pharma, doi:10.1007/s00210-023-02610-6
El-Sewedy, Salama, Mohamed, Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in targeting AMPK/mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death, BMC Complement Med Ther
El-Shehawy, Elmetwalli, El-Far, Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches, BMC Complement Med Ther
Elumalai, Muninathan, Megalatha, An insight into anticancer effect of propolis and its constituents: a review of molecular mechanisms, Evid Based Complement Altern Med
Elwakeel, Soudan, Eldoksh, Implementation of the Chou-Talalay method for studying the in vitro pharmacodynamic interactions of binary and ternary drug combinations on MDA-MB-231 triple negative breast cancer cells, Synergy
Gandhi, Maisnam, Rathore, Respiratory illness virus infections with special emphasis on COVID-19, Eur J Med Res
Giannenas, Sidiropoulou, Bonos, The history of herbs, medicinal and aromatic plants, and their extracts: past, current situation and future perspectives
Gunjan, Naing, Saini, Marketing trends & future prospects of herbal medicine in the treatment of various disease, World J Pharm Res
Hashem, silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors
Hossain, Quispe, Khan, Propolis: an update on its chemistry and pharmacological applications, Chin Med
Howes, Quave, Collemare, Molecules from nature: reconciling biodiversity conservation and global healthcare imperatives for sustainable use of medicinal plants and fungi, Plants, People, Planet
Jang, Shin, Lee, Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2, Sci Rep
Jebaranjitham, Christyraj, Prasannan, Current scenario of solid waste management techniques and challenges in Covid-19-a review, Heliyon
Jiang, Rubin, Zhou, Pharmacological therapies and drug development targeting SARS-CoV-2 infection, Cytokine Growth Factor Rev, doi:10.1016/j.cytogfr.2022.10.003
Joshi, Joshi, Semwal, Curcumin: an insight into molecular pathways involved in anticancer activity, Mini Rev Med Chem
Kah, Chandran, Abrahamse, Curcumin a natural phenol and its therapeutic role in cancer and photodynamic therapy: a review, Pharmaceutics
Kandeel, Moatasim, Fahim, Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality, BMC Infect Dis
Ko, Rolain, Lee, Arguments in favour of remdesivir for treating SARS-CoV-2 infections, Int J Antimicrob Agents
Koryukov, Kechin, Shamovskaya, Do sputnik V vaccineinduced antibodies protect against seasonal coronaviruses? Case study, Viral Immunol
Kraiem, Hamouda, Eleroui, Anti-Inflammatory and immunomodulatory properties of a crude polysaccharide derived from green seaweed Halimeda tuna: computational and experimental evidences, Mar Drugs
Kumar, Dhanjal, Kaul, Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity, J Biomol Struct Dyn
Kurek-Górecka, Rzepecka-Stojko, Górecki, Structure and antioxidant activity of polyphenols derived from propolis, Molecules
Land, Role of damage-associated molecular patterns in light of modern environmental research: a tautological approach, Int J Environ Res
Laurindo, Marton, Minniti, Exploring the impact of herbal therapies on COVID-19 and influenza: investigating novel delivery mechanisms for emerging interventions, Biologics
Li, Cao, Li, Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models, J Med Chem
Magnavacca, Sangiovanni, Racagni, Agli, The antiviral and immunomodulatory activities of propolis: an update and future perspectives for respiratory diseases, Med Res Rev
Meo, Palma, Bruzzese, Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment, J Transl Med
Merarchi, Dudha, Das, Garg, Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs, Phyther Res
Mitran, Mitran, Popa, Antioxidants as defense mechanisms against viral pathogens, Proc Rom Acad Ser B
Mousa, Abdel-Razik, Mousa, Coagulopathy in COVID-19 from pathogenesis until treatment: a systemic review, Med J Viral Hepat
Mrityunjaya, Pavithra, Neelam, Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19, Front Immunol
Nema, Mamdapur, Sarojam, Preventive medicinal plants and their phytoconstituents against SARS-CoV-2/COVID-19, Pharmacogn Rev
Njeru, Muema, In vitro cytotoxicity of Aspilia pluriseta Schweinf. extract fractions, BMC Res Notes
Omar, Bouziane, Bouslama, Djemel, In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxychloroquine against COVID-19 main protease active site and ACE2, Chem, doi:10.26434/chemrxiv.12181404.v1
Pawar, Usman, Patil, Patil, Profile access and treatment of minor symptoms as first line of defense against prevalent viral attack, J Coast Life Med
Peng, Pan, Cao, Liu, Potential oral health benefits of ginseng and its extracts, Int Dent J, doi:10.1016/j.identj.2023.02.004
Petrillo, Orrù, Fais, Fantini, Quercetin and its derivates as antiviral potentials: a comprehensive review, Phyther Res
Potenza, Montagnani, Santacroce, Ancient herbal therapy: a brief history of Panax ginseng, J Ginseng Res
Qiu, Guitian, Webster, Global prioritization of endemic zoonotic diseases for conducting surveillance in domestic animals to protect public health, Philos Trans R Soc B Biol Sci, doi:10.1098/rstb.2022.0407
Rabaan, Sh, Sah, SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic, Ann Clin Microbiol Antimicrob
Rath, Mccann, Cohn, Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs, J Ovarian Res
Rathore, Mukim, Sharma, Curcumin: a review for health benefits, Int J Res Rev
Ripari, Sartori, Da Silva, Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment, J Pharm Pharmacol
Rolfo, Cosma, Nuzzo, Increased placental antioxidant response in asymptomatic and symptomatic COVID-19 third-trimester pregnancies, Biomedicines
Roy, Khan, Ahmad, Flavonoids a bioactive compound from medicinal plants and its therapeutic applications, Biomed Res Int, doi:10.1155/2022/5445291
Ryan, Teaching and learning during the COVID-19 pandemic
Sahlan, Irdiani, Flamandita, Molecular interaction analysis of Sulawesi propolis compounds with SARS-CoV-2 main protease as preliminary study for COVID-19 drug discovery, J King Saud Univ
Salatino, Perspectives for uses of propolis in therapy against infectious diseases, Molecules
Salmerón-Manzano, Garrido-Cardenas, Manzano-Agugliaro, Worldwide research trends on medicinal plants, Int J Environ Res Public Health
Sangboonruang, Semakul, Sookkree, Activity of propolis nanoparticles against HSV-2: promising approach to inhibiting infection and replication, Molecules
Sartaj, Baboota, Ali, Assessment of combination approaches of phytoconstituents with chemotherapy for the treatment of breast cancer: a systematic review, Curr Pharm Des
Sberna, Biagi, Marafini, In vitro evaluation of antiviral efficacy of a standardized hydroalcoholic extract of poplar type propolis against SARS-CoV-2, Front Microbiol
Sforcin, Biological properties and therapeutic applications of propolis, Phyther Res
Slanina, Madhugiri, Bylapudi, Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit, Proc Natl Acad Sci
Sopjani, Falco, Impellitteri, Flavonoids derived from medicinal plants as a COVID 19 treatment, Phyther Res
Straková, Bednář, Kotouček, Antiviral activity of singlet oxygenphotogenerating perylene compounds against SARS-CoV-2: interaction with the viral envelope and photodynamic virion inactivation, Virus Res
Subositi, Wahyono, Study of the genus Curcuma in Indonesia used as traditional herbal medicines, Biodiversitas J Biol Divers, doi:10.13057/biodiv/d200527
Sun, Zou, Song, A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer, Acta Pharm Sin B
To, Tsang, Yip, Consistent detection of 2019 novel coronavirus in saliva, Clin Infect Dis
Xian, Zhang, Bian, Bioactive natural compounds against human coronaviruses: a review and perspective, Acta Pharm Sin B
Yosri, El-Wahed, Ghonaim, Antiviral and immunomodulatory properties of propolis: Chemical diversity, pharmacological properties, preclinical and clinical applications, and in silico potential against SARS-CoV-2, Foods
Zahedipour, Hosseini, Sathyapalan, Potential effects of curcumin in the treatment of COVID-19 infection, Phyther Res
Zhang, Liu, Potential interventions for novel coronavirus in China: a systematic review, J Med Virol
Zia, Muhammad, Bibi, Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies, Bioorg Med Chem Lett
Zinovkin, Grebenchikov, Transcription factor Nrf2 as a potential therapeutic target for prevention of cytokine storm in COVID-19 patients, Biochem
Zulhendri, Chandrasekaran, Kowacz, Antiviral, antibacterial, antifungal, and antiparasitic properties of propolis: a review, Foods
{ 'indexed': { 'date-parts': [[2024, 11, 28]], 'date-time': '2024-11-28T05:37:25Z', 'timestamp': 1732772245003, 'version': '3.29.0'}, 'reference-count': 94, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2024, 11, 27]], 'date-time': '2024-11-27T00:00:00Z', 'timestamp': 1732665600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0'}, { 'start': { 'date-parts': [[2024, 11, 27]], 'date-time': '2024-11-27T00:00:00Z', 'timestamp': 1732665600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'abstract': '<jats:title>Abstract</jats:title><jats:p>There is an urgent need for preventive and ' 'therapeutic drugs to effectively treat and prevent viral diseases from resurfacing as they ' 'emerge during the COVID-19 pandemic. This study aims to assess the antiviral effects of four ' 'natural compounds commonly used in traditional medicine to treat SARS-CoV-2 infection. A ' 'cytotoxicity, dose-dependent, and plaque reduction assay was performed on Vero CCL-81 cells ' 'to figure out their effects on the cells. Quantification of cytokines was assessed. In silico ' 'analysis for the selected compound was also evaluated. Results revealed that the compounds ' 'could disrupt the viral replication cycle through direct inhibition of the virus or immune ' 'system stimulation. The cytotoxicity assay results revealed that the compounds were well ' 'tolerated by the cells, indicating that the compounds were not toxic to the cells. This study ' 'evaluated the antioxidant capacities of propolis, curcumin, quercetin, and ginseng using ' 'ABTS, FRAP, and CUPRAC assays, revealing that propolis exhibited the highest antioxidant ' 'activity of ABTS with 1250.40\u2009±\u200917.10\xa0μmol Trolox eq/g, with FRAP values ' 'reaching 1200.55\u2009±\u200915.90\xa0μmol Fe<jats:sup>2</jats:sup>⁺ eq/g and CUPRAC values ' 'of 1150.80\u2009±\u200914.20\xa0μmol Trolox eq/g at 1000\xa0µg/mL, highlighting its potential ' 'as a potent natural antioxidant. The results of the plaque reduction assay revealed that the ' 'compounds could reduce the size and number of plaques, indicating that the compounds could ' 'inhibit the virus replication cycle. Subsequently, using molecular docking to analyze the ' 'effect of propolis, curcumin, quercetin, and ginseng as inhibitors, it was unveiled that the ' 'four compounds are likely to have the potential to inhibit the protease activity, spike ' 'protein S1, and RNA polymerase of SARS-CoV-2 and the virus titer was reduced by 100% after ' 'post-infection using propolis as an inhibitor control.</jats:p>\n' ' <jats:p><jats:bold>Graphical Abstract</jats:bold></jats:p>', 'DOI': '10.1186/s40643-024-00822-z', 'type': 'journal-article', 'created': { 'date-parts': [[2024, 11, 27]], 'date-time': '2024-11-27T21:09:01Z', 'timestamp': 1732741741000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Assessing multi-target antiviral and antioxidant activities of natural compounds against ' 'SARS-CoV-2: an integrated in vitro and in silico study', 'prefix': '10.1186', 'volume': '11', 'author': [ {'given': 'Aisha Nawaf', 'family': 'Al balawi', 'sequence': 'first', 'affiliation': []}, {'given': 'Jayda G.', 'family': 'Eldiasty', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Sahar Abd-El Razik', 'family': 'Mosallam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alaa R.', 'family': 'El-Alosey', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-5372-4297', 'authenticated-orcid': False, 'given': 'Alaa', 'family': 'Elmetwalli', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 11, 27]]}, 'reference': [ { 'key': '822_CR1', 'first-page': '79', 'volume': '13', 'author': 'HS Abbas', 'year': '2023', 'unstructured': 'Abbas HS, Abd-Elhakeem MM, Abd El Galil RM et al (2023) Natural ' 'immunomodulators treat the cytokine storm in SARS-CoV-2. Adv Pharm Bull ' '13:79', 'journal-title': 'Adv Pharm Bull'}, { 'key': '822_CR2', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.btre.2022.e00749', 'volume': '35', 'author': 'DH Abou Baker', 'year': '2022', 'unstructured': 'Abou Baker DH (2022) Can natural products modulate cytokine storm in ' 'SARS-CoV2 patients? Biotechnol Reports 35:e00749', 'journal-title': 'Biotechnol Reports'}, { 'key': '822_CR3', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/978-3-030-71165-8', 'volume-title': 'Human viruses: diseases, treatments and vaccines: the new insights', 'author': 'SI Ahmad', 'year': '2021', 'unstructured': 'Ahmad SI (2021) Human viruses: diseases, treatments and vaccines: the ' 'new insights. Springer Nature, Berlin'}, { 'key': '822_CR4', 'doi-asserted-by': 'publisher', 'first-page': '1024', 'DOI': '10.3390/microorganisms11041024', 'volume': '11', 'author': 'AN AlBalawi', 'year': '2023', 'unstructured': 'AlBalawi AN, Elmetwalli A, Baraka DM et al (2023) Chemical constituents, ' 'antioxidant potential, and antimicrobial efficacy of Pimpinella anisum ' 'extracts against multidrug-resistant bacteria. Microorganisms 11:1024', 'journal-title': 'Microorganisms'}, { 'key': '822_CR5', 'doi-asserted-by': 'crossref', 'unstructured': 'Allam Z, Jones DS (2020) On the coronavirus (COVID-19) outbreak and the ' 'smart city network: universal data sharing standards coupled with ' 'artificial intelligence (AI) to benefit urban health monitoring and ' 'management. In: Healthcare. MDPI. 46', 'DOI': '10.3390/healthcare8010046'}, { 'key': '822_CR6', 'doi-asserted-by': 'publisher', 'first-page': '4095', 'DOI': '10.3390/molecules26134095', 'volume': '26', 'author': 'A Alsayari', 'year': '2021', 'unstructured': 'Alsayari A, Bin MA, Almaghaslah D et al (2021) Pharmacological efficacy ' 'of ginseng against respiratory tract infections. Molecules 26:4095', 'journal-title': 'Molecules'}, { 'key': '822_CR7', 'doi-asserted-by': 'publisher', 'first-page': '1825', 'DOI': '10.1002/jmv.27588', 'volume': '94', 'author': 'Y Araf', 'year': '2022', 'unstructured': 'Araf Y, Akter F, Tang Y et al (2022) Omicron variant of SARS-CoV-2: ' 'genomics, transmissibility, and responses to current COVID-19 vaccines. ' 'J Med Virol 94:1825–1832', 'journal-title': 'J Med Virol'}, { 'key': '822_CR8', 'doi-asserted-by': 'publisher', 'first-page': 'e200342', 'DOI': '10.1590/0074-02760200342', 'volume': '115', 'author': 'DB Araujo', 'year': '2020', 'unstructured': 'Araujo DB, Machado RRG, Amgarten DE et al (2020) SARS-CoV-2 isolation ' 'from the first reported patients in Brazil and establishment of a ' 'coordinated task network. Mem Inst Oswaldo Cruz 115:e200342', 'journal-title': 'Mem Inst Oswaldo Cruz'}, { 'key': '822_CR9', 'first-page': '56', 'volume': '1', 'author': 'M Asif', 'year': '2022', 'unstructured': 'Asif M, Pasha MA, Shafiq S, Craine I (2022) Economic impacts of post ' 'COVID-19. Inverge J Soc Sci 1:56–65', 'journal-title': 'Inverge J Soc Sci'}, { 'key': '822_CR10', 'doi-asserted-by': 'publisher', 'first-page': '3579', 'DOI': '10.3390/nu14173579', 'volume': '14', 'author': 'ST Asma', 'year': '2022', 'unstructured': 'Asma ST, Bobiş O, Bonta V et al (2022) General nutritional profile of ' 'bee products and their potential antiviral properties against mammalian ' 'viruses. Nutrients 14:3579', 'journal-title': 'Nutrients'}, { 'key': '822_CR11', 'doi-asserted-by': 'publisher', 'first-page': '6842', 'DOI': '10.1080/07391102.2020.1803139', 'volume': '39', 'author': 'R Badraoui', 'year': '2021', 'unstructured': 'Badraoui R, Alrashedi MM, El-May MV, Bardakci F (2021) Acute respiratory ' 'distress syndrome: a life threatening associated complication of ' 'SARS-CoV-2 infection inducing COVID-19. J Biomol Struct Dyn 39:6842–6851', 'journal-title': 'J Biomol Struct Dyn'}, { 'key': '822_CR12', 'doi-asserted-by': 'publisher', 'first-page': '129', 'DOI': '10.3390/ph15020129', 'volume': '15', 'author': 'R Badraoui', 'year': '2022', 'unstructured': 'Badraoui R, Saoudi M, Hamadou WS et al (2022) Antiviral effects of ' 'artemisinin and its derivatives against SARS-CoV-2 main protease: ' 'computational evidences and interactions with ACE2 allelic variants. ' 'Pharmaceuticals 15:129', 'journal-title': 'Pharmaceuticals'}, { 'key': '822_CR13', 'doi-asserted-by': 'publisher', 'first-page': '109133', 'DOI': '10.1016/j.celrep.2021.109133', 'volume': '35', 'author': 'K Bafna', 'year': '2021', 'unstructured': 'Bafna K, White K, Harish B et al (2021) Hepatitis C virus drugs that ' 'inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to ' 'suppress viral replication in cell culture. Cell Rep 35:109133', 'journal-title': 'Cell Rep'}, { 'key': '822_CR14', 'doi-asserted-by': 'publisher', 'DOI': '10.7759/cureus.28467', 'author': 'T Bakacs', 'year': '2022', 'unstructured': 'Bakacs T, Sandig V, Kovesdi I (2022) An orally administered ' 'nonpathogenic attenuated vaccine virus can be used to control SARS-CoV-2 ' 'infection: a complementary plan B to COVID-19 vaccination. Cureus. ' 'https://doi.org/10.7759/cureus.28467', 'journal-title': 'Cureus'}, { 'key': '822_CR15', 'doi-asserted-by': 'publisher', 'first-page': '3997', 'DOI': '10.1097/MS9.0000000000001057', 'volume': '85', 'author': 'M Bardhan', 'year': '2023', 'unstructured': 'Bardhan M, Ray I, Roy S et al (2023) Emerging zoonotic diseases and ' 'COVID-19 pandemic: global perspective and Indian scenario. Ann Med Surg ' '85:3997–4004', 'journal-title': 'Ann Med Surg'}, { 'key': '822_CR16', 'doi-asserted-by': 'publisher', 'first-page': 'e20345', 'DOI': '10.1590/s2175-97902022e20345', 'volume': '58', 'author': 'H Ben-Nasr', 'year': '2022', 'unstructured': 'Ben-Nasr H, Badraoui R (2022) Approach of utilizing Artemisia herbs to ' 'treat covid-19. Brazilian J Pharm Sci 58:e20345', 'journal-title': 'Brazilian J Pharm Sci'}, { 'key': '822_CR17', 'doi-asserted-by': 'publisher', 'first-page': '110622', 'DOI': '10.1016/j.biopha.2020.110622', 'volume': '131', 'author': 'AA Berretta', 'year': '2020', 'unstructured': 'Berretta AA, Silveira MAD, Capcha JMC, De Jong D (2020) Propolis and its ' 'potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: ' 'running title: propolis against SARS-CoV-2 infection and COVID-19. ' 'Biomed Pharmacother 131:110622', 'journal-title': 'Biomed Pharmacother'}, { 'key': '822_CR18', 'doi-asserted-by': 'publisher', 'first-page': '2528', 'DOI': '10.3390/nu13082528', 'volume': '13', 'author': 'P Bhargava', 'year': '2021', 'unstructured': 'Bhargava P, Mahanta D, Kaul A et al (2021) Experimental evidence for ' 'therapeutic potentials of propolis. Nutrients 13:2528', 'journal-title': 'Nutrients'}, { 'key': '822_CR19', 'doi-asserted-by': 'publisher', 'first-page': '4856', 'DOI': '10.1007/s12035-020-02074-2', 'volume': '57', 'author': 'JS Bhatti', 'year': '2020', 'unstructured': 'Bhatti JS, Bhatti GK, Khullar N et al (2020) Therapeutic strategies in ' 'the development of antiviral drugs and vaccines against SARS-CoV-2 ' 'infection. Mol Neurobiol 57:4856–4877', 'journal-title': 'Mol Neurobiol'}, { 'key': '822_CR20', 'doi-asserted-by': 'publisher', 'first-page': '2705', 'DOI': '10.3390/nu11112705', 'volume': '11', 'author': 'A Braakhuis', 'year': '2019', 'unstructured': 'Braakhuis A (2019) Evidence on the health benefits of supplemental ' 'propolis. Nutrients 11:2705', 'journal-title': 'Nutrients'}, { 'key': '822_CR21', 'doi-asserted-by': 'publisher', 'first-page': '4', 'DOI': '10.2174/0929867328666210521164809', 'volume': '29', 'author': 'M Costanzo', 'year': '2022', 'unstructured': 'Costanzo M, De Giglio MAR, Roviello GN (2022) Anti-coronavirus vaccines: ' 'past investigations on SARS-CoV-1 and MERS-CoV, the approved vaccines ' 'from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under ' 'development against SARSCoV-2 infection. Curr Med Chem 29:4–18', 'journal-title': 'Curr Med Chem'}, { 'key': '822_CR22', 'doi-asserted-by': 'publisher', 'first-page': '2530', 'DOI': '10.2174/0929867328666210726094955', 'volume': '29', 'author': 'LNO da Cunha', 'year': '2022', 'unstructured': 'da Cunha LNO, Tizziani T, Souza GB et al (2022) Natural products with ' 'tandem anti-inflammatory, immunomodulatory and anti-SARS-CoV/2 effects: ' 'a drug discovery perspective against SARS-CoV-2. Curr Med Chem ' '29:2530–2564', 'journal-title': 'Curr Med Chem'}, { 'key': '822_CR23', 'doi-asserted-by': 'publisher', 'first-page': 'e031', 'DOI': '10.1590/1807-3107bor-2023.vol37.0031', 'volume': '37', 'author': 'SHC de Sales-Peres', 'year': '2023', 'unstructured': 'de Sales-Peres SHC, de Azevedo-Silva LJ, Castilho AVSS et al (2023) ' 'Propolis effects in periodontal disease seem to affect coronavirus ' 'disease: a meta-analysis. Braz Oral Res 37:e031', 'journal-title': 'Braz Oral Res'}, { 'key': '822_CR24', 'doi-asserted-by': 'publisher', 'first-page': '2498', 'DOI': '10.3390/molecules27082498', 'volume': '27', 'author': 'MPK Deepika', 'year': '2022', 'unstructured': 'Deepika MPK (2022) Health benefits of quercetin in age-related diseases. ' 'Molecules 27:2498', 'journal-title': 'Molecules'}, { 'key': '822_CR25', 'doi-asserted-by': 'publisher', 'first-page': '384', 'DOI': '10.1016/j.arcmed.2020.04.019', 'volume': '51', 'author': 'L Delgado-Roche', 'year': '2020', 'unstructured': 'Delgado-Roche L, Mesta F (2020) Oxidative stress as key player in severe ' 'acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med ' 'Res 51:384–387', 'journal-title': 'Arch Med Res'}, { 'key': '822_CR26', 'doi-asserted-by': 'publisher', 'first-page': '247', 'DOI': '10.1007/978-3-030-96569-3_12', 'volume-title': 'Artificial intelligence for innovative healthcare informatics', 'author': 'SA Desai', 'year': '2022', 'unstructured': 'Desai SA, Mahitha G (2022) Ayurnano: a solution towards herbal ' 'therapeutics using artificial intelligence approach. In: Parah SA, ' 'Rashid M, Varadarajan V (eds) Artificial intelligence for innovative ' 'healthcare informatics. Springer, Cham, pp 247–262'}, { 'key': '822_CR27', 'doi-asserted-by': 'publisher', 'first-page': '266', 'DOI': '10.1002/ptr.7309', 'volume': '36', 'author': 'A Di Petrillo', 'year': '2022', 'unstructured': 'Di Petrillo A, Orrù G, Fais A, Fantini MC (2022) Quercetin and its ' 'derivates as antiviral potentials: a comprehensive review. Phyther Res ' '36:266–278', 'journal-title': 'Phyther Res'}, { 'key': '822_CR28', 'doi-asserted-by': 'publisher', 'first-page': 'e1009127', 'DOI': '10.1371/journal.ppat.1009127', 'volume': '16', 'author': 'SSG Dias', 'year': '2020', 'unstructured': 'Dias SSG, Soares VC, Ferreira AC et al (2020) Lipid droplets fuel ' 'SARS-CoV-2 replication and production of inflammatory mediators. PLoS ' 'Pathog 16:e1009127', 'journal-title': 'PLoS Pathog'}, { 'key': '822_CR29', 'doi-asserted-by': 'publisher', 'first-page': '873', 'DOI': '10.3390/v13050873', 'volume': '13', 'author': 'RJ Eberle', 'year': '2021', 'unstructured': 'Eberle RJ, Olivier DS, Amaral MS et al (2021) The repurposed drugs ' 'suramin and quinacrine cooperatively inhibit SARS-CoV-2 3CLpro in vitro. ' 'Viruses 13:873', 'journal-title': 'Viruses'}, { 'key': '822_CR30', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00210-023-02610-6', 'author': 'AR El-Alosey', 'year': '2023', 'unstructured': 'El-Alosey AR, Eldiasty JG, Abushalfeh IYH et al (2023) Perceptions of ' 'medicinal herbal products during the COVID-19 pandemic period among ' 'Saudi patients: a cross-sectional study. Naunyn Schmiedebergs Arch ' 'Pharmacol. https://doi.org/10.1007/s00210-023-02610-6', 'journal-title': 'Naunyn Schmiedebergs Arch Pharmacol'}, { 'key': '822_CR31', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s12906-023-04142-1', 'volume': '23', 'author': 'T El-Sewedy', 'year': '2023', 'unstructured': 'El-Sewedy T, Salama AF, Mohamed AE et al (2023) Hepatocellular Carcinoma ' 'cells: activity of Amygdalin and Sorafenib in targeting AMPK/mTOR and ' 'BCL-2 for anti-angiogenesis and apoptosis cell death. BMC Complement Med ' 'Ther 23:1–17', 'journal-title': 'BMC Complement Med Ther'}, { 'key': '822_CR32', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s12906-023-03872-6', 'volume': '23', 'author': 'AA El-Shehawy', 'year': '2023', 'unstructured': 'El-Shehawy AA, Elmetwalli A, El-Far AH et al (2023) Thymoquinone, ' 'piperine, and sorafenib combinations attenuate liver and breast cancers ' 'progression: epigenetic and molecular docking approaches. BMC Complement ' 'Med Ther 23:1–21', 'journal-title': 'BMC Complement Med Ther'}, { 'key': '822_CR33', 'doi-asserted-by': 'publisher', 'first-page': '5901191', 'DOI': '10.1155/2022/5901191', 'volume': '2022', 'author': 'P Elumalai', 'year': '2022', 'unstructured': 'Elumalai P, Muninathan N, Megalatha ST et al (2022) An insight into ' 'anticancer effect of propolis and its constituents: a review of ' 'molecular mechanisms. Evid Based Complement Altern Med 2022:5901191', 'journal-title': 'Evid Based Complement Altern Med'}, { 'key': '822_CR34', 'doi-asserted-by': 'publisher', 'first-page': '100047', 'DOI': '10.1016/j.synres.2019.100047', 'volume': '8', 'author': 'A Elwakeel', 'year': '2019', 'unstructured': 'Elwakeel A, Soudan H, Eldoksh A et al (2019) Implementation of the ' 'Chou-Talalay method for studying the in vitro pharmacodynamic ' 'interactions of binary and ternary drug combinations on MDA-MB-231 ' 'triple negative breast cancer cells. Synergy 8:100047', 'journal-title': 'Synergy'}, { 'key': '822_CR35', 'doi-asserted-by': 'publisher', 'first-page': '158', 'DOI': '10.3390/biologics3030009', 'volume': '3', 'author': 'L Fornari Laurindo', 'year': '2023', 'unstructured': 'Fornari Laurindo L, Taynara Marton L, Minniti G et al (2023) Exploring ' 'the impact of herbal therapies on COVID-19 and influenza: investigating ' 'novel delivery mechanisms for emerging interventions. Biologics ' '3:158–186', 'journal-title': 'Biologics'}, { 'key': '822_CR36', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s40001-022-00874-x', 'volume': '27', 'author': 'L Gandhi', 'year': '2022', 'unstructured': 'Gandhi L, Maisnam D, Rathore D et al (2022) Respiratory illness virus ' 'infections with special emphasis on COVID-19. Eur J Med Res 27:1–21', 'journal-title': 'Eur J Med Res'}, { 'key': '822_CR37', 'first-page': '1', 'volume-title': 'Feed additives', 'author': 'I Giannenas', 'year': '2020', 'unstructured': 'Giannenas I, Sidiropoulou E, Bonos E et al (2020) The history of herbs, ' 'medicinal and aromatic plants, and their extracts: past, current ' 'situation and future perspectives. In: Florou-Paneri P, Christaki E, ' 'Giannenas I (eds) Feed additives. Elsevier, Amsterdam, pp 1–18'}, { 'key': '822_CR38', 'first-page': '132', 'volume': '4', 'author': 'M Gunjan', 'year': '2015', 'unstructured': 'Gunjan M, Naing TW, Saini RS et al (2015) Marketing trends & future ' 'prospects of herbal medicine in the treatment of various disease. World ' 'J Pharm Res 4:132–155', 'journal-title': 'World J Pharm Res'}, { 'key': '822_CR39', 'doi-asserted-by': 'crossref', 'unstructured': 'Hashem H (2020) In silico approach of some selected honey constituents ' 'as SARS-CoV-2 main protease (COVID-19) inhibitors', 'DOI': '10.26434/chemrxiv.12115359'}, { 'key': '822_CR40', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s13020-022-00651-2', 'volume': '17', 'author': 'R Hossain', 'year': '2022', 'unstructured': 'Hossain R, Quispe C, Khan RA et al (2022) Propolis: an update on its ' 'chemistry and pharmacological applications. Chin Med 17:1–60', 'journal-title': 'Chin Med'}, { 'key': '822_CR41', 'doi-asserted-by': 'publisher', 'first-page': '463', 'DOI': '10.1002/ppp3.10138', 'volume': '2', 'author': 'MR Howes', 'year': '2020', 'unstructured': 'Howes MR, Quave CL, Collemare J et al (2020) Molecules from nature: ' 'reconciling biodiversity conservation and global healthcare imperatives ' 'for sustainable use of medicinal plants and fungi. Plants, People, ' 'Planet 2:463–481', 'journal-title': 'Plants, People, Planet'}, { 'key': '822_CR42', 'doi-asserted-by': 'publisher', 'first-page': '821', 'DOI': '10.1038/s41598-020-80896-9', 'volume': '11', 'author': 'Y Jang', 'year': '2021', 'unstructured': 'Jang Y, Shin H, Lee MK et al (2021) Antiviral activity of ' 'lambda-carrageenan against influenza viruses and severe acute ' 'respiratory syndrome coronavirus 2. Sci Rep 11:821', 'journal-title': 'Sci Rep'}, { 'key': '822_CR43', 'doi-asserted-by': 'publisher', 'first-page': 'e09855', 'DOI': '10.1016/j.heliyon.2022.e09855', 'volume': '8', 'author': 'JN Jebaranjitham', 'year': '2022', 'unstructured': 'Jebaranjitham JN, Christyraj JDS, Prasannan A et al (2022) Current ' 'scenario of solid waste management techniques and challenges in ' 'Covid-19-a review. Heliyon 8:e09855', 'journal-title': 'Heliyon'}, { 'key': '822_CR44', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cytogfr.2022.10.003', 'author': 'Y Jiang', 'year': '2022', 'unstructured': 'Jiang Y, Rubin L, Zhou Z et al (2022) Pharmacological therapies and drug ' 'development targeting SARS-CoV-2 infection. Cytokine Growth Factor Rev. ' 'https://doi.org/10.1016/j.cytogfr.2022.10.003', 'journal-title': 'Cytokine Growth Factor Rev'}, { 'key': '822_CR45', 'doi-asserted-by': 'publisher', 'first-page': '2420', 'DOI': '10.2174/1389557521666210122153823', 'volume': '21', 'author': 'P Joshi', 'year': '2021', 'unstructured': 'Joshi P, Joshi S, Semwal D et al (2021) Curcumin: an insight into ' 'molecular pathways involved in anticancer activity. Mini Rev Med Chem ' '21:2420–2457', 'journal-title': 'Mini Rev Med Chem'}, { 'key': '822_CR46', 'doi-asserted-by': 'publisher', 'first-page': '639', 'DOI': '10.3390/pharmaceutics15020639', 'volume': '15', 'author': 'G Kah', 'year': '2023', 'unstructured': 'Kah G, Chandran R, Abrahamse H (2023) Curcumin a natural phenol and its ' 'therapeutic role in cancer and photodynamic therapy: a review. ' 'Pharmaceutics 15:639', 'journal-title': 'Pharmaceutics'}, { 'key': '822_CR47', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s12879-023-08527-y', 'volume': '23', 'author': 'A Kandeel', 'year': '2023', 'unstructured': 'Kandeel A, Moatasim Y, Fahim M et al (2023) Comparison of SARS-Cov-2 ' 'omicron variant with the previously identified SARS-Cov-2 variants in ' 'Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its ' 'impact on epidemiology, clinical picture, disease severity, and ' 'mortality. BMC Infect Dis 23:1–12', 'journal-title': 'BMC Infect Dis'}, { 'key': '822_CR48', 'doi-asserted-by': 'publisher', 'first-page': '105933', 'DOI': '10.1016/j.ijantimicag.2020.105933', 'volume': '55', 'author': 'W-C Ko', 'year': '2020', 'unstructured': 'Ko W-C, Rolain J-M, Lee N-Y et al (2020) Arguments in favour of ' 'remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents ' '55:105933', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '822_CR49', 'doi-asserted-by': 'publisher', 'first-page': '138', 'DOI': '10.1089/vim.2021.0157', 'volume': '35', 'author': 'M Koryukov', 'year': '2022', 'unstructured': 'Koryukov M, Kechin A, Shamovskaya D et al (2022) Do sputnik V ' 'vaccine-induced antibodies protect against seasonal coronaviruses? Case ' 'study. Viral Immunol 35:138–141', 'journal-title': 'Viral Immunol'}, { 'key': '822_CR50', 'doi-asserted-by': 'publisher', 'first-page': '85', 'DOI': '10.3390/md22020085', 'volume': '22', 'author': 'M Kraiem', 'year': '2024', 'unstructured': 'Kraiem M, Ben Hamouda S, Eleroui M et al (2024) Anti-Inflammatory and ' 'immunomodulatory properties of a crude polysaccharide derived from green ' 'seaweed Halimeda tuna: computational and experimental evidences. Mar ' 'Drugs 22:85', 'journal-title': 'Mar Drugs'}, { 'key': '822_CR51', 'doi-asserted-by': 'publisher', 'first-page': '3842', 'DOI': '10.1080/07391102.2020.1772108', 'volume': '39', 'author': 'V Kumar', 'year': '2021', 'unstructured': 'Kumar V, Dhanjal JK, Kaul SC et al (2021) Withanone and caffeic acid ' 'phenethyl ester are predicted to interact with main protease (Mpro) of ' 'SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn 39:3842–3854', 'journal-title': 'J Biomol Struct Dyn'}, { 'key': '822_CR52', 'doi-asserted-by': 'publisher', 'first-page': '78', 'DOI': '10.3390/molecules19010078', 'volume': '19', 'author': 'A Kurek-Górecka', 'year': '2013', 'unstructured': 'Kurek-Górecka A, Rzepecka-Stojko A, Górecki M et al (2013) Structure and ' 'antioxidant activity of polyphenols derived from propolis. Molecules ' '19:78–101', 'journal-title': 'Molecules'}, { 'key': '822_CR53', 'doi-asserted-by': 'publisher', 'first-page': '583', 'DOI': '10.1007/s41742-020-00276-z', 'volume': '14', 'author': 'WG Land', 'year': '2020', 'unstructured': 'Land WG (2020) Role of damage-associated molecular patterns in light of ' 'modern environmental research: a tautological approach. Int J Environ ' 'Res 14:583–604', 'journal-title': 'Int J Environ Res'}, { 'key': '822_CR54', 'doi-asserted-by': 'publisher', 'first-page': '2785', 'DOI': '10.1021/acs.jmedchem.0c01929', 'volume': '65', 'author': 'Y Li', 'year': '2021', 'unstructured': 'Li Y, Cao L, Li G et al (2021) Remdesivir metabolite GS-441524 ' 'effectively inhibits SARS-CoV-2 infection in mouse models. J Med Chem ' '65:2785–2793', 'journal-title': 'J Med Chem'}, { 'key': '822_CR55', 'doi-asserted-by': 'publisher', 'first-page': '897', 'DOI': '10.1002/med.21866', 'volume': '42', 'author': 'A Magnavacca', 'year': '2022', 'unstructured': 'Magnavacca A, Sangiovanni E, Racagni G, Dell’Agli M (2022) The antiviral ' 'and immunomodulatory activities of propolis: an update and future ' 'perspectives for respiratory diseases. Med Res Rev 42:897–945', 'journal-title': 'Med Res Rev'}, { 'key': '822_CR56', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s12967-023-04110-w', 'volume': '21', 'author': 'C Meo', 'year': '2023', 'unstructured': 'Meo C, Palma G, Bruzzese F et al (2023) Spontaneous cancer remission ' 'after COVID-19: insights from the pandemic and their relevance for ' 'cancer treatment. J Transl Med 21:1–13', 'journal-title': 'J Transl Med'}, { 'key': '822_CR57', 'doi-asserted-by': 'publisher', 'first-page': '5384', 'DOI': '10.1002/ptr.7151', 'volume': '35', 'author': 'M Merarchi', 'year': '2021', 'unstructured': 'Merarchi M, Dudha N, Das BC, Garg M (2021) Natural products and ' 'phytochemicals as potential anti-SARS-CoV-2 drugs. Phyther Res ' '35:5384–5396', 'journal-title': 'Phyther Res'}, { 'key': '822_CR58', 'first-page': '189', 'volume': '23', 'author': 'CI Mitran', 'year': '2021', 'unstructured': 'Mitran CI, Mitran MI, Popa MI (2021) Antioxidants as defense mechanisms ' 'against viral pathogens. Proc Rom Acad Ser B 23:189–195', 'journal-title': 'Proc Rom Acad Ser B'}, { 'key': '822_CR59', 'doi-asserted-by': 'publisher', 'first-page': '3', 'DOI': '10.21608/mjvh.2021.158270', 'volume': '5', 'author': 'N Mousa', 'year': '2021', 'unstructured': 'Mousa N, Abdel-Razik A, Mousa E et al (2021) Coagulopathy in COVID-19 ' 'from pathogenesis until treatment: a systemic review. Med J Viral Hepat ' '5:3–8', 'journal-title': 'Med J Viral Hepat'}, { 'key': '822_CR60', 'doi-asserted-by': 'publisher', 'first-page': '570122', 'DOI': '10.3389/fimmu.2020.570122', 'volume': '11', 'author': 'M Mrityunjaya', 'year': '2020', 'unstructured': 'Mrityunjaya M, Pavithra V, Neelam R et al (2020) Immune-boosting, ' 'antioxidant and anti-inflammatory food supplements targeting ' 'pathogenesis of COVID-19. Front Immunol 11:570122', 'journal-title': 'Front Immunol'}, { 'key': '822_CR61', 'doi-asserted-by': 'publisher', 'first-page': '173', 'DOI': '10.5530/pres.13.4.10', 'volume': '13', 'author': 'NK Nema', 'year': '2021', 'unstructured': 'Nema NK, Mamdapur GMN, Sarojam S et al (2021) Preventive medicinal ' 'plants and their phytoconstituents against SARS-CoV-2/COVID-19. ' 'Pharmacogn Rev 13:173', 'journal-title': 'Pharmacogn Rev'}, { 'key': '822_CR62', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s13104-021-05472-4', 'volume': '14', 'author': 'SN Njeru', 'year': '2021', 'unstructured': 'Njeru SN, Muema JM (2021) In vitro cytotoxicity of Aspilia pluriseta ' 'Schweinf. extract fractions. BMC Res Notes 14:1–4', 'journal-title': 'BMC Res Notes'}, { 'key': '822_CR63', 'doi-asserted-by': 'publisher', 'unstructured': 'Omar S, Bouziane I, Bouslama Z, Djemel A (2020) In-silico identification ' 'of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin ' 'converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, ' 'and cirsimaritin exhibited better potential inhibition than ' 'hydroxy-chloroquine against COVID-19 main protease active site and ACE2. ' 'Chem. https://doi.org/10.26434/chemrxiv.12181404.v1', 'DOI': '10.26434/chemrxiv.12181404.v1'}, { 'key': '822_CR64', 'first-page': '907', 'volume': '11', 'author': 'SR Pawar', 'year': '2023', 'unstructured': 'Pawar SR, Usman MRM, Patil BP, Patil AD (2023) Profile access and ' 'treatment of minor symptoms as first line of defense against prevalent ' 'viral attack. J Coast Life Med 11:907–912', 'journal-title': 'J Coast Life Med'}, { 'key': '822_CR65', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.identj.2023.02.004', 'author': 'Y Peng', 'year': '2023', 'unstructured': 'Peng Y, Pan W, Cao X, Liu C (2023) Potential oral health benefits of ' 'ginseng and its extracts. Int Dent J. ' 'https://doi.org/10.1016/j.identj.2023.02.004', 'journal-title': 'Int Dent J'}, { 'key': '822_CR66', 'doi-asserted-by': 'publisher', 'first-page': '359', 'DOI': '10.1016/j.jgr.2022.03.004', 'volume': '47', 'author': 'MA Potenza', 'year': '2023', 'unstructured': 'Potenza MA, Montagnani M, Santacroce L et al (2023) Ancient herbal ' 'therapy: a brief history of Panax ginseng. J Ginseng Res 47:359–365', 'journal-title': 'J Ginseng Res'}, { 'key': '822_CR67', 'doi-asserted-by': 'publisher', 'first-page': '20220407', 'DOI': '10.1098/rstb.2022.0407', 'volume': '378', 'author': 'Y Qiu', 'year': '2023', 'unstructured': 'Qiu Y, Guitian J, Webster JP et al (2023) Global prioritization of ' 'endemic zoonotic diseases for conducting surveillance in domestic ' 'animals to protect public health. Philos Trans R Soc B Biol Sci ' '378:20220407. https://doi.org/10.1098/rstb.2022.0407', 'journal-title': 'Philos Trans R Soc B Biol Sci'}, { 'key': '822_CR68', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s12941-020-00384-w', 'volume': '19', 'author': 'AA Rabaan', 'year': '2020', 'unstructured': 'Rabaan AA, Al-Ahmed SH, Sah R et al (2020) SARS-CoV-2/COVID-19 and ' 'advances in developing potential therapeutics and vaccines to counter ' 'this emerging pandemic. Ann Clin Microbiol Antimicrob 19:1–37', 'journal-title': 'Ann Clin Microbiol Antimicrob'}, { 'key': '822_CR69', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/1757-2215-6-35', 'volume': '6', 'author': 'KS Rath', 'year': '2013', 'unstructured': 'Rath KS, McCann GA, Cohn DE et al (2013) Safe and targeted anticancer ' 'therapy for ovarian cancer using a novel class of curcumin analogs. J ' 'Ovarian Res 6:1–12', 'journal-title': 'J Ovarian Res'}, { 'key': '822_CR70', 'first-page': '273', 'volume': '7', 'author': 'S Rathore', 'year': '2020', 'unstructured': 'Rathore S, Mukim M, Sharma P et al (2020) Curcumin: a review for health ' 'benefits. Int J Res Rev 7:273–290', 'journal-title': 'Int J Res Rev'}, { 'key': '822_CR71', 'doi-asserted-by': 'publisher', 'first-page': '281', 'DOI': '10.1093/jpp/rgaa067', 'volume': '73', 'author': 'N Ripari', 'year': '2021', 'unstructured': 'Ripari N, Sartori AA, da Silva HM et al (2021) Propolis antiviral and ' 'immunomodulatory activity: a review and perspectives for COVID-19 ' 'treatment. J Pharm Pharmacol 73:281–299', 'journal-title': 'J Pharm Pharmacol'}, { 'key': '822_CR72', 'doi-asserted-by': 'publisher', 'first-page': '634', 'DOI': '10.3390/biomedicines10030634', 'volume': '10', 'author': 'A Rolfo', 'year': '2022', 'unstructured': 'Rolfo A, Cosma S, Nuzzo AM et al (2022) Increased placental antioxidant ' 'response in asymptomatic and symptomatic COVID-19 third-trimester ' 'pregnancies. Biomedicines 10:634', 'journal-title': 'Biomedicines'}, { 'key': '822_CR73', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2022/5445291', 'author': 'A Roy', 'year': '2022', 'unstructured': 'Roy A, Khan A, Ahmad I et al (2022) Flavonoids a bioactive compound from ' 'medicinal plants and its therapeutic applications. Biomed Res Int. ' 'https://doi.org/10.1155/2022/5445291', 'journal-title': 'Biomed Res Int'}, { 'key': '822_CR74', 'doi-asserted-by': 'publisher', 'first-page': '14', 'DOI': '10.4324/9781003324096-2', 'volume-title': 'Pandemic pedagogies', 'author': 'JM Ryan', 'year': '2023', 'unstructured': 'Ryan JM (2023) Teaching and learning during the COVID-19 pandemic. In: ' 'Ryan JM (ed) Pandemic pedagogies. Routledge, London, pp 14–30'}, { 'key': '822_CR75', 'doi-asserted-by': 'publisher', 'first-page': '101234', 'DOI': '10.1016/j.jksus.2020.101234', 'volume': '33', 'author': 'M Sahlan', 'year': '2021', 'unstructured': 'Sahlan M, Irdiani R, Flamandita D et al (2021) Molecular interaction ' 'analysis of Sulawesi propolis compounds with SARS-CoV-2 main protease as ' 'preliminary study for COVID-19 drug discovery. J King Saud Univ ' '33:101234', 'journal-title': 'J King Saud Univ'}, { 'key': '822_CR76', 'doi-asserted-by': 'publisher', 'first-page': '4594', 'DOI': '10.3390/molecules27144594', 'volume': '27', 'author': 'A Salatino', 'year': '2022', 'unstructured': 'Salatino A (2022) Perspectives for uses of propolis in therapy against ' 'infectious diseases. Molecules 27:4594', 'journal-title': 'Molecules'}, { 'key': '822_CR77', 'doi-asserted-by': 'publisher', 'first-page': '3376', 'DOI': '10.3390/ijerph17103376', 'volume': '17', 'author': 'E Salmerón-Manzano', 'year': '2020', 'unstructured': 'Salmerón-Manzano E, Garrido-Cardenas JA, Manzano-Agugliaro F (2020) ' 'Worldwide research trends on medicinal plants. Int J Environ Res Public ' 'Health 17:3376', 'journal-title': 'Int J Environ Res Public Health'}, { 'key': '822_CR78', 'doi-asserted-by': 'publisher', 'first-page': '2560', 'DOI': '10.3390/molecules27082560', 'volume': '27', 'author': 'S Sangboonruang', 'year': '2022', 'unstructured': 'Sangboonruang S, Semakul N, Sookkree S et al (2022) Activity of propolis ' 'nanoparticles against HSV-2: promising approach to inhibiting infection ' 'and replication. Molecules 27:2560', 'journal-title': 'Molecules'}, { 'key': '822_CR79', 'doi-asserted-by': 'publisher', 'first-page': '4630', 'DOI': '10.2174/1381612827666210902155752', 'volume': '27', 'author': 'A Sartaj', 'year': '2021', 'unstructured': 'Sartaj A, Baboota S, Ali J (2021) Assessment of combination approaches ' 'of phytoconstituents with chemotherapy for the treatment of breast ' 'cancer: a systematic review. Curr Pharm Des 27:4630–4648', 'journal-title': 'Curr Pharm Des'}, { 'key': '822_CR80', 'doi-asserted-by': 'publisher', 'first-page': '799546', 'DOI': '10.3389/fmicb.2022.799546', 'volume': '13', 'author': 'G Sberna', 'year': '2022', 'unstructured': 'Sberna G, Biagi M, Marafini G et al (2022) In vitro evaluation of ' 'antiviral efficacy of a standardized hydroalcoholic extract of poplar ' 'type propolis against SARS-CoV-2. Front Microbiol 13:799546', 'journal-title': 'Front Microbiol'}, { 'key': '822_CR81', 'doi-asserted-by': 'publisher', 'first-page': '894', 'DOI': '10.1002/ptr.5605', 'volume': '30', 'author': 'JM Sforcin', 'year': '2016', 'unstructured': 'Sforcin JM (2016) Biological properties and therapeutic applications of ' 'propolis. Phyther Res 30:894–905', 'journal-title': 'Phyther Res'}, { 'key': '822_CR82', 'doi-asserted-by': 'publisher', 'first-page': 'e2022310118', 'DOI': '10.1073/pnas.2022310118', 'volume': '118', 'author': 'H Slanina', 'year': '2021', 'unstructured': 'Slanina H, Madhugiri R, Bylapudi G et al (2021) Coronavirus ' 'replication–transcription complex: Vital and selective NMPylation of a ' 'conserved site in nsp9 by the NiRAN-RdRp subunit. Proc Natl Acad Sci ' '118:e2022310118', 'journal-title': 'Proc Natl Acad Sci'}, { 'key': '822_CR83', 'doi-asserted-by': 'publisher', 'first-page': '1589', 'DOI': '10.1002/ptr.8123', 'volume': '38', 'author': 'M Sopjani', 'year': '2024', 'unstructured': 'Sopjani M, Falco F, Impellitteri F et al (2024) Flavonoids derived from ' 'medicinal plants as a COVID 19 treatment. Phyther Res 38:1589–1609', 'journal-title': 'Phyther Res'}, { 'key': '822_CR84', 'doi-asserted-by': 'publisher', 'first-page': '199158', 'DOI': '10.1016/j.virusres.2023.199158', 'volume': '334', 'author': 'P Straková', 'year': '2023', 'unstructured': 'Straková P, Bednář P, Kotouček J et al (2023) Antiviral activity of ' 'singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: ' 'interaction with the viral envelope and photodynamic virion ' 'inactivation. Virus Res 334:199158', 'journal-title': 'Virus Res'}, { 'key': '822_CR85', 'doi-asserted-by': 'publisher', 'DOI': '10.13057/biodiv/d200527', 'author': 'D Subositi', 'year': '2019', 'unstructured': 'Subositi D, Wahyono S (2019) Study of the genus Curcuma in Indonesia ' 'used as traditional herbal medicines. Biodiversitas J Biol Divers. ' 'https://doi.org/10.13057/biodiv/d200527', 'journal-title': 'Biodiversitas J Biol Divers'}, { 'key': '822_CR86', 'doi-asserted-by': 'publisher', 'first-page': '378', 'DOI': '10.1016/j.apsb.2021.06.005', 'volume': '12', 'author': 'D Sun', 'year': '2022', 'unstructured': 'Sun D, Zou Y, Song L et al (2022) A cyclodextrin-based nanoformulation ' 'achieves co-delivery of ginsenoside Rg3 and quercetin for ' 'chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B 12:378–393', 'journal-title': 'Acta Pharm Sin B'}, { 'key': '822_CR87', 'doi-asserted-by': 'publisher', 'first-page': '841', 'DOI': '10.1093/cid/ciaa149', 'volume': '71', 'author': 'KK-W To', 'year': '2020', 'unstructured': 'To KK-W, Tsang OT-Y, Yip CC-Y et al (2020) Consistent detection of 2019 ' 'novel coronavirus in saliva. Clin Infect Dis 71:841–843', 'journal-title': 'Clin Infect Dis'}, { 'key': '822_CR88', 'doi-asserted-by': 'publisher', 'first-page': '1163', 'DOI': '10.1016/j.apsb.2020.06.002', 'volume': '10', 'author': 'Y Xian', 'year': '2020', 'unstructured': 'Xian Y, Zhang J, Bian Z et al (2020) Bioactive natural compounds against ' 'human coronaviruses: a review and perspective. Acta Pharm Sin B ' '10:1163–1174', 'journal-title': 'Acta Pharm Sin B'}, { 'key': '822_CR89', 'doi-asserted-by': 'publisher', 'first-page': '1776', 'DOI': '10.3390/foods10081776', 'volume': '10', 'author': 'N Yosri', 'year': '2021', 'unstructured': 'Yosri N, Abd El-Wahed AA, Ghonaim R et al (2021) Antiviral and ' 'immunomodulatory properties of propolis: Chemical diversity, ' 'pharmacological properties, preclinical and clinical applications, and ' 'in silico potential against SARS-CoV-2. Foods 10:1776', 'journal-title': 'Foods'}, { 'key': '822_CR90', 'doi-asserted-by': 'publisher', 'first-page': '2911', 'DOI': '10.1002/ptr.6738', 'volume': '34', 'author': 'F Zahedipour', 'year': '2020', 'unstructured': 'Zahedipour F, Hosseini SA, Sathyapalan T et al (2020) Potential effects ' 'of curcumin in the treatment of COVID-19 infection. Phyther Res ' '34:2911–2920', 'journal-title': 'Phyther Res'}, { 'key': '822_CR91', 'doi-asserted-by': 'publisher', 'first-page': '479', 'DOI': '10.1002/jmv.25707', 'volume': '92', 'author': 'L Zhang', 'year': '2020', 'unstructured': 'Zhang L, Liu Y (2020) Potential interventions for novel coronavirus in ' 'China: a systematic review. J Med Virol 92:479–490', 'journal-title': 'J Med Virol'}, { 'key': '822_CR92', 'doi-asserted-by': 'publisher', 'first-page': '128079', 'DOI': '10.1016/j.bmcl.2021.128079', 'volume': '43', 'author': 'M Zia', 'year': '2021', 'unstructured': 'Zia M, Muhammad S, Bibi S et al (2021) Exploring the potential of novel ' 'phenolic compounds as potential therapeutic candidates against ' 'SARS-CoV-2, using quantum chemistry, molecular docking and dynamic ' 'studies. Bioorg Med Chem Lett 43:128079', 'journal-title': 'Bioorg Med Chem Lett'}, { 'key': '822_CR93', 'first-page': '833', 'volume': '85', 'author': 'RA Zinovkin', 'year': '2020', 'unstructured': 'Zinovkin RA, Grebenchikov OA (2020) Transcription factor Nrf2 as a ' 'potential therapeutic target for prevention of cytokine storm in ' 'COVID-19 patients. Biochem 85:833–837', 'journal-title': 'Biochem'}, { 'key': '822_CR94', 'doi-asserted-by': 'publisher', 'first-page': '1360', 'DOI': '10.3390/foods10061360', 'volume': '10', 'author': 'F Zulhendri', 'year': '2021', 'unstructured': 'Zulhendri F, Chandrasekaran K, Kowacz M et al (2021) Antiviral, ' 'antibacterial, antifungal, and antiparasitic properties of propolis: a ' 'review. Foods 10:1360', 'journal-title': 'Foods'}], 'container-title': 'Bioresources and Bioprocessing', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1186/s40643-024-00822-z.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1186/s40643-024-00822-z/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1186/s40643-024-00822-z.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 11, 27]], 'date-time': '2024-11-27T22:03:13Z', 'timestamp': 1732744993000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://bioresourcesbioprocessing.springeropen.com/articles/10.1186/s40643-024-00822-z'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 11, 27]]}, 'references-count': 94, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 12]]}}, 'alternative-id': ['822'], 'URL': 'http://dx.doi.org/10.1186/s40643-024-00822-z', 'relation': {}, 'ISSN': ['2197-4365'], 'subject': [], 'container-title-short': 'Bioresour. Bioprocess.', 'published': {'date-parts': [[2024, 11, 27]]}, 'assertion': [ { 'value': '6 August 2024', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '31 October 2024', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '27 November 2024', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'Not applicable.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics approval consent to participate'}}, { 'value': 'Not applicable.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent for publication'}}, { 'value': 'The authors declare no competing interests.', 'order': 4, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}], 'article-number': '108'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit